Treating posttraumatic stress disorder in substance use disorder patients with co-occurring posttraumatic stress disorder: study protocol for a randomized controlled trial to compare the effectiveness of different types and timings of treatment

BMC Psychiatry

Loes A. Marquenie¹  Marleen M. de Waal¹  Sera A. Lortye¹  Joanne P. Will¹  Anna E. Goudriaan²  Arnoud Arntz³ 

[1] Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands;Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands;Amsterdam UMC, Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands;Amsterdam Public Health Research Institute, Amsterdam, The Netherlands;Department of Clinical Psychology, University of Amsterdam, Amsterdam, The Netherlands;

关键词: Post-traumatic stress disorder;    Substance use disorder;    Prolonged exposure;    Eye movement desensitization and reprocessing;    Imagery rescripting;    Treatment timing;    Simultaneous;    Sequential;    Trauma-focused treatment;   

DOI  :  10.1186/s12888-021-03366-0

来源: Springer

【 摘 要 】

BackgroundPosttraumatic stress disorder (PTSD) and substance use disorder (SUD) have high comorbidity. Although prior research indicated that PTSD can effectively be treated with Prolonged Exposure (PE) in these patients, reported effects are small and treatment dropout rates high. Eye Movement Desensitization and Reprocessing (EMDR) and Imagery Rescripting (ImRs) are other promising treatment options for PTSD, that have not yet been examined in this patient group. Furthermore, it is unclear whether PTSD treatment is most effective when offered simultaneous to or after SUD treatment.MethodsIn this article, the Treatment Of PTSD and Addiction (TOPA) study is described: a Dutch randomized controlled trial (RCT) that studies the effectiveness of PTSD treatment as an add-on to regular SUD treatment in patients with SUD and co-occurring PTSD. Effects of PE, EMDR, ImRs, and a 3-month SUD treatment only condition will be compared, as well as simultaneous SUD/PTSD treatment to sequential SUD/PTSD treatment. The primary outcome measure is PTSD symptoms. Secondary outcomes are: treatment completion, psychological distress, substance use, interpersonal problems, emotion dysregulation, and trauma-related emotions guilt, shame, and anger.DiscussionThis study is the first to compare effects of PE, EMDR, and ImRs in one study and to compare simultaneous SUD/PTSD treatment to sequential SUD/PTSD treatment as well. This RCT will provide more knowledge about the effectiveness of different treatment strategies for PTSD in patients with co-occurring SUD and will ultimately improve treatment outcomes for patients with this common co-morbidity worldwide.Trial registrationNetherlands Trial Register (NTR), Identifier: NL7885. Registered 22 July 2019.

【 授权许可】

CC BY